There are several types of recombinant therapeutic antibodies and proteins, including monoclonal antibodies, antibody-drug conjugates, and cytokines. Monoclonal antibodies are antibodies that are created using a single type of immune cell, which allows them to bind to a specific molecule or cell in the body. Antibody-drug conjugates are molecules that combine a monoclonal antibody with a cytotoxic drug, which allows the antibody to deliver the drug directly to cancer cells. Cytokines are proteins that play a key role in regulating the immune system, and can be used to treat a variety of diseases.
Recombinant Therapeutic Antibodies and Proteins have revolutionized the field of medicine, and have provided new treatment options for many patients. However, these molecules can be expensive to produce, and may not be accessible to all patients. In addition, there are concerns about the potential for these molecules to cause side effects, particularly in the long-term.
